RecruitingNCT05388682

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement


Sponsor

Chinese Pulmonary Vascular Disease Research Group

Enrollment

200 participants

Start Date

Jan 19, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement


Eligibility

Inclusion Criteria1

  • patients diagnosed with Takayasu arteries with pulmonary arteries involvement

Exclusion Criteria1

  • Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPercutaneous transluminal pulmonary angioplasty

Percutaneous transluminal pulmonary angioplasty


Locations(1)

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05388682


Related Trials